Elevance Health Inc. (ELV)
NYSE: ELVHealth CareMedical SpecialitiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 405.00 +0.17%
ELV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $87.68B
- P/E (TTM)
- 17.90
- Forward P/E
- 13.69
- EPS (TTM)
- $22.59
- Dividend yield
- 1.70% ($6.86)
- Ex-dividend date
- Sep 10, 2026
- 52-week range
- 274.84 – 436.24
- Day range
- 400.19 – 410.54
- Volume / Avg
- 904.66K / 1.20M
- Beta
- —
- Shares outstanding
- 216.87M
- Next earnings
- Oct 21, 2026
52-week range
ELV stock today
Shares of Elevance Health (ELV) finished higher on Oct 7 at $404.31, a gain of 1.05% or $4.22 per share, versus the S&P 500's 0.22% decline. Shares are 7.3% below their 52-week high of $436.24, set on Jul 14, 2026 and 47.1% above the 52-week low of $274.84, near the top of the past year's range. ELV is up 16.1% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 13.9%.
At 17.9x trailing earnings, Elevance Health trades below the peer-group median of 25.6x. Its forward P/E of 13.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Oct 21 before the market opens; analysts expect EPS of $4.66. Elevance Health pays an annual dividend of $6.86 per share, a 1.70% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Elevance Health
Company profileElevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Ms. Gail Koziara Boudreaux
- Headquarters
- Indianapolis, IN
- Employees
- 96,129
- Website
- elevancehealth.com
Financial highlights
Full financialsIn fiscal 2025, Elevance Health generated $199.13 billion in revenue, up 12.5% from fiscal 2024, its 15th consecutive year of revenue growth. Net income was $5.66 billion (-5.3% year over year), for a net margin of 2.8% versus a median of 3.8% in the prior 5 years. Gross margin was 89.4% (up from 88.8%) and operating margin 3.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $199.13B | $177.01B | $171.34B | $156.59B | $138.64B |
| Growth | +12.49% | +3.31% | +9.42% | +12.95% | +13.76% |
| Net income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
| EPS (diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
Analyst forecast
ForecastConsensus (22 analysts)
buy
Avg. price target
$451.48+11.67%
- Strong buy 3
- Buy 12
- Hold 7
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 21, 2026
- EPS estimate
- $4.66
- Last reported (Q2 2026)
- Jul 15, 2026
- EPS actual vs est.
- $6.71 vs —
Dividends
Dividend history- Annual dividend
- $6.86
- Dividend yield
- 1.70%
- Last payment
- $1.72
- Ex-dividend date
- Sep 10, 2026
ELV news
All ELV news- Centene's Operations Improve: Does the 12.34X P/E Make it a Buy?NasdaqCNC, UNH, ELV
- UnitedHealth Q3 Coming Up: Two Questions Investors Can't IgnoreNasdaqUNH, HUM, ELV
- HHS finalizes updated price transparency rules for healthcare costsSeeking Alpha
- ELV or DHR: Which Is the Better Value Stock Right Now?NasdaqELV, DHR
- Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?NasdaqELV, AMWL
- PRF, GM, ELV, F: Large Inflows Detected at ETFNasdaqPRF, GM, ELV, F
- How Centene's Strong Cash Flow Is Reshaping Its Balance SheetNasdaqCNC, MOH, ELV
- Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?NasdaqELV, AMWL
Elevance Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CIThe Cigna Group | 278.51 | +1.51% | $73.59B | vs ELV |
| NTRANatera Inc. | 395.56 | -1.27% | $57.02B | vs ELV |
| HUMHumana Inc. | 396.51 | -1.92% | $47.61B | vs ELV |
| ILMNIllumina Inc. | 267.76 | -2.11% | $40.43B | vs ELV |
| CNCCentene Corporation | 64.99 | +0.59% | $32.10B | vs ELV |
| LHLabcorp Holdings Inc. | 311.97 | +0.08% | $25.30B | vs ELV |
| DGXQuest Diagnostics Incorporated | 227.06 | -0.58% | $25.06B | vs ELV |
| GHGuardant Health Inc. | 168.33 | -1.38% | $22.59B | vs ELV |
Indexes, lists and sector
Index membership
Appears in lists
Elevance Health stock FAQ
What is Elevance Health's stock price today?
ELV last traded at $404.31 as of Oct 7, 4:00 PM EDT, up 1.05% on the day. Prices are delayed at least 15 minutes.
Does Elevance Health pay a dividend?
Yes. Elevance Health pays $6.86 per share annually, a 1.70% yield. The most recent dividend of $1.72 had an ex-dividend date of Sep 10, 2026.
When is Elevance Health's next earnings date?
Elevance Health is expected to report earnings on Wednesday, October 21, 2026. Analysts expect EPS of $4.66.
What is ELV's P/E ratio?
ELV trades at a trailing P/E ratio of 17.90 and a forward P/E of 13.69, compared with a median of 25.6 for its closest peers.
Is Elevance Health in the S&P 500?
Yes. Elevance Health (ELV) is a constituent of the S&P 500 index.
Who is Elevance Health's CEO?
Ms. Gail Koziara Boudreaux is the chief executive officer of Elevance Health Inc., which has about 96,129 employees.
Has ELV ever split its stock?
Yes. The most recent ELV stock split was a 2-for-1 split on Jun 1, 2005.